awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33415437-990325B7-A770-4FE2-94DB-7F1F64865DBD
Q33415437-990325B7-A770-4FE2-94DB-7F1F64865DBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415437-990325B7-A770-4FE2-94DB-7F1F64865DBD
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors.
P2860
Q33415437-990325B7-A770-4FE2-94DB-7F1F64865DBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415437-990325B7-A770-4FE2-94DB-7F1F64865DBD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5bf8843e72e59d9c6b2101adb56fdd4116b14722
P2860
A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors.